Danishsmith0118 May, 2021Health
The biggest challenge for a biopharmaceutical company is to provide a high-quality product in a cost-efficient manner. The necessity to harness the first-to-market advantage similarly as meet the growing pressure to manage prices from customers, insurance firms and governments has led several biopharmaceutical manufacturers to resort to innovative ways of production. Implementation of process intensification (continuous manufacturing) and use of disposable technologies has significantly boosted the assembly productivities. Integration of applied mathematics modeling with commonplace bioprocess improvement strategies has also been a positive strategy in achieving the goals of quicker production time and better method design.
888pvin
Thomson Bruce
Haslund Leach
Hede Mcleod
Deleon Korsholm
Nilsson Timmermann
Epstein Harding
Binderup Phillips
Ohlsen Riise
Hardin Egeberg